Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab vs Lenalidomide vs Combination in Recurrent Follicular NHL
NCT00238238Phase 2Completed
- Sponsor
- Cancer and Leukemia Group B
- Start
- Mar 2006
- Primary completion
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lenalidomide in follicular lymphoma (FL), sponsored by Cancer and Leukemia Group B. Started Mar 2006; status: completed.
02
Drugs
lenalidomide
03
Conditions
follicular lymphoma (FL)
Beyond the preview
Go deeper on NCT00238238.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00238238.